9th April 2018 RMOC Recommendation: Standardising strengths of high risk, unlicensed oral liquids formulations for anti-TB medicines At the meeting on 26th October 2017 the Regional Medicines Optimisation Committee (North) endorsed the approach put forward by the NHS Pharmaceutical Quality Assurance Committee…
Didn’t find what you were looking for? If you need to know more you can ask one of our experts for help. Ask a question